Example: Heart Attack

Clinical Trials on Hypercalcemia

Total 43 results

  • NCT05152927
    Active, not recruiting
    Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
    Conditions: Parathyroid Diseases, Parathyroid Dysfunction, Parathyroid Neoplasms, Parathyroid Adenoma, Hypercalcemia, Neoplasms, Glandular and Epithelial, Endocrine Gland Neoplasms, Adenoma, Hyperparathyroidism, Hyperparathyroidism, Primary
  • NCT00001277
    Completed
    Studies of Elevated Parathyroid Activity
    Conditions: Hyperparathyroidism, Hypercalcemia, Parathyroid Neoplasm, Multiple Endocrine Neoplasia, MEN1
  • NCT00458796
    Terminated
    Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone
    Conditions: Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer, Musculoskeletal Complications, Pain
  • NCT04299425
    Recruiting
    Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy
    Conditions: Parathyroid Adenoma, Parathyroid Neoplasms, Parathyroid Hyperplasia, Parathyroid Cancer, Hypercalcemia, Primary Hyperparathyroidism
  • NCT03516747
    Withdrawn
    Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland
    Conditions: Parathyroid Adenoma, Hypercalcemia
  • NCT03301038
    Recruiting
    Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
    Conditions: Idiopathic Infantile Hypercalcaemia - Severe Form, Genetic Disease, Hypercalcemia, Idiopathic, of Infancy, Hypercalciuric Hypercalcemia, Idiopathic Infantile Hypercalcemia - Mild Form, Hypercalciuria
  • NCT04256369
    Completed
    Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes
    Conditions: Hyperphosphatemia, Hyperkalemia, Hypermagnesemia, Hypercalcemia
  • NCT05022641
    Recruiting
    Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
    Conditions: Parathyroid Adenoma, Parathyroid Neoplasms, Parathyroid Cancer, Hypercalcemia, Primary Hyperparathyroidism
  • NCT03384121
    Recruiting
    The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH
    Conditions: Idiopathic Infantile Hypercalcemia - Mild Form
  • NCT04265599
    Recruiting
    Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil
    Conditions: Hypercalcemia, Renal Injury, Paraffinoma
  • NCT04987073
    Enrolling by invitation
    Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency
    Conditions: Idiopathic Infantile Hypercalcemia - Severe Form
  • NCT02908542
    Completed
    Search for New Genetic Causes of Hypercalcemia by Massively Parallel Sequencing of a Genes Panel
    Conditions: Hypercalcemia
  • NCT04872894
    Recruiting
    Familial Hypocalciuric Hypercalcemia: Clinical Aspects and Evolution
    Conditions: Familial Hypocalciuric Hypercalcemia
  • NCT01648842
    Completed
    Vitamin D and Preeclampsia
    Conditions: Vitamin D Deficiency Defined as Serum 25OHD < 75 Nmol/l or 30ng/ml, Preeclampsia, Neonatal Hypercalcemia, Pregnancy
  • NCT00415584
    Terminated
    Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
    Conditions: Secondary Hyperparathyroidism, Hypercalcemia
  • NCT04292288
    Recruiting
    Hypercalcemia After Paraffin Oil Injection
    Conditions: Hypercalcemia, Granuloma
  • NCT02711059
    Withdrawn
    Insulin Resistance in Primary Hyperparathyroidism
    Conditions: Hyperparathyroidism, Diabetes, Hypercalcemia
  • NCT04198480
    Not yet recruiting
    A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM
    Conditions: Hypercalcemia of Malignancy
  • NCT03935984
    Recruiting
    Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
    Conditions: Primary Hyperparathyroidism, Hypercalcemia
  • NCT00485706
    Completed
    Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients
    Conditions: Kidney Disease, Hypercalcemia
  • NCT00896454
    Completed
    Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
    Conditions: Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer, Endocrine Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Metastatic Cancer, Multiple Myeloma, Parathyroid Neoplasms, Renal Cancer, Thyroid Cancer, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Non-Small Cell Lung Cancer
  • NCT00975221
    Completed
    Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
    Conditions: Hyperparathyroidism, Primary, Hypercalcemia
  • NCT00325104
    Completed
    Cinacalcet to Treat Familial Primary Hyperparathyroidism
    Conditions: Hypercalcemia, Familial Primary Hyperparathyroidism
  • NCT02023489
    Unknown status
    Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations
    Conditions: Type 2 Diabetes Mellitus, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Familiar Hypocalcuric Hypercalcemia, Healthy Volunteers, Type 1 Diabetes Mellitus
  • NCT01460030
    Completed
    An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
    Conditions: Parathyroid Carcinoma, Hypercalcemia, Primary Hyperparathyroidism

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations